Join A&M Healthcare Industry Group's Marthe Haverkamp, M.D., Ph.D, as she sits down with world-renowned virologist Ab Osterhaus, Ph.D., and vaccine expert Manon Cox, Ph.D., MBA, Chief Executive Officer and Co-Founder of NextWaveBio. They discuss the future of vaccines, the value of COVID-19 treatments, and the influence of Omicron on the pandemic: Is a relatively mild disease now a comparative advantage for the future?
https://www.alvarezandmarsal.com/insights/is-omicron-our-way-out
Aaron Gillingham, Senior Vice President & Chief Human Resources Officer at UnityPoint Health, joins A&M’s Bianca A. Briola for Episode 2 of The Future...
As the Medicare Advantage market faces mounting pressure, Clover Health is taking a different approach. Jamie Reynoso, CEO of Medicare Advantage at Clover Health...
The recent rise in labor costs is impacting operations for U.S. healthcare organizations. Listen to A&M Healthcare Industry Group's latest podcast to learn how...
